Menu

Experience

Madison Jones

    • SpringWorks Therapeutics – $186 Million IPO  


    • NextCure – $86 Million IPO 


    • PhaseBio Pharmaceuticals – $46 Million IPO 


    • Endava – $146 Million IPO 


    • Endava – $146 Million IPO 


    • Recro Pharma – $15 Million Follow-On  


    • AveXis – $95 Million IPO 


    • Tenable – $288 Million IPO 


Contact us

Back to top

© 2019 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.